You are here: Industry Insights > clinical data

News List

Weekly Pharma News Review | PharmaSources.com （Feb.6th - 10th, 2023） Caicai
February 13, 2023
A new indication of Pfizer's tofacitinib sustained release tablet was approved in China; Phase III study of obesity indication of Eli Lilly's Tirzepatide succeeded in China.
Free EDC software for non-profit COVID-19 related studies worldpharmanews
March 20, 2020
Italy-based EDC provider, Nubilaria srl, offers its ACTide EDC pro-bono for European non-profit COVID-19 Coronavirus related studies.
Takeda maintenance data set up Ninlaro for new myeloma nod fiercepharma
December 05, 2018
Takeda’s Ninlaro has watched from the sidelines as competing multiple myeloma drugs jumped into additional indications. But now it may finally be ready to do the same.
ASH: Can Johnson & Johnson sell regulators on Xarelto as clot prevention for cancer patients? fiercepharma
December 05, 2018
Johnson & Johnson's clot-busting Xarelto may not have hit the primary goal in its latest trial, but the company still believes it can win a new approval down the line—and as the drug's laundry list of current indications shows...
ASH: Johnson & Johnson's fast-growing Darzalex lines up for 2nd front-line myeloma OK fiercepharma
December 05, 2018
Johnson & Johnson’s Darzalex made multiple myeloma history this May when it became the first monoclonal antibody to score an FDA approval in newly diagnosed patients. And now, it’s looking to make it a repeat.
Clinical Data Management Leaders Reveal Underlying Challenges Impacting Trial Timelines americanpharmaceuticalreview
June 27, 2018
At the upcoming DIA 2018 Annual Meeting, Tufts Center for the Study of Drug Development (CSDD) will preview its study findings on the root causes for delays and inefficiencies impacting trial timelines.